Surgical Infection Control Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2018 - 2028

  • Single User License $3500

Surgical Infection Control Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2018 - 2028

Status : July, 2020 | Medical Devices | PPT format

Report Digest


Surgical Infection Control Market Introduction

Health care associated infections (HCAIs) or surgical site infections are the infections acquired among patients during their hospital stay, creating needs for surgical infection control. HCAIs or surgical site infections usually lead to more overnight stays for treatment, causing more suffering for the patient, and also affects the overall health economy.

Hospitals and other healthcare organizations are adopting surgical infection control products and solutions to improve their surgical outcomes and surgical success rates by avoiding surgical site infections. Surgical infection control products, such as disinfectants, surgical drapes, gloves, scrubs, skin Preparation Solutions and, medial nonwovens, are witnessing burgeoning demand across the global healthcare industry, triggering growth of the surgical infection control market. 

Surgical Infection Control Market – Notable Developments

  • The 3M Company – an American multinational conglomerate – introduced its new product, SoluPrep™ Film-Forming Sterile Surgical Solution, which is skin preparation solution, in October 2018. The company declared that the new surgical infection control product is a 2% chlorhexidine gluconate and 70% isopropyl alcohol surgical skin preparation solution uses 3M’s polymer and adhesive technology and can be used to fight against surgical site infections.
  • Getinge AB – a Sweden-based technology company and leading player in the surgical infection control market – launched a new surgical light Maquet PowerLED II in October 2019. This is an antibacterial coating that can minimizing risks of cross-contamination and prevent the spread of infections in operating rooms. The company also announced that the new surgical infection control coating can also be used in laminar air flow environments with an open ring design.
  • Kimberly-Clark Corporation – another leading company in the surgical infection control market – recently announced that it has approved a US$ 30 million investment in nonwovens manufacturing facility in Hendersonville, North Carolina. The company will be focusing on focus on improving efficiency and expanding the company’s nonwoven materials production capacity.
  • In November 2017, Ansell – a global leader in protection solutions – introduced the first hybrid surgical glove, which is a combination of two non-latex polymers – polyisoprene (PI) and neoprene – that can offer the strength and durability of neoprene along with the latex-like comfort of PI. The company announced that the GAMMEX PI Hybrid glove, made with patent-pending Ansell HYBRID Technology, will help surgeons and healthcare professionals to implement surgical infection control by minimizing chemical Type IV allergies and sensitivities to chemical accelerators. 

Some of the most prominent competitors operating in the competitive landscape of global surgical infection control market include –

  • 3M Company
  • Belimed AG
  • Becton
  • Dickinson and Company
  • Kimberly-Clark
  • Biomerieux SA
  • Johnson & Johnson
  • Getinge Group
  • Sotera Health
  • Lac-Mac Limited
  • Ansell Limited
  • Steris Corporation
  • American Polyfilm Inc.
  • Pacon Manufacturing Corp

Surgical Infection Control Market Dynamics

Increasing Incidents of Surgical Site Infections Boosts Growth of the Surgical Infection Control Market

At least 1 in 25 hospitalized patients suffer from healthcare-related infections, such as surgical site infections (SSIs), according to the Center for Disease Control and Prevention. In the United States (U.S.), the number of SSIs associated with inpatient surgeries was around 157,500 in 2011 and, in 2014, over 14.2 million operative procedures were performed in the inpatient setting, which signifies increased risk of SSIs, creating needs for surgical infection control products.

Not only in the U.S., but the need for surgical infection control products has also been on the rise in the European region. According to the ‘Surgical site infections - Annual Epidemiological Report 2016’ by the European Centre for Disease Prevention and Control, a significant rise in the incidents of SSIs was observed during 2011-2014, especially following  cholecystectomy operations. Thereby, an increasing number of hospitals in the region are adopting surgical infection control products. This is expected to complement growth of the surgical infection control market in the upcoming years.

Adoption Advanced Technologies in Surgical Infection Control will Reduce Potential Surgical Complications

Growing awareness about the potential risks of SSIs is triggering adoption of surgical infection control products and this is driving growth of the surgical infection control market. With the increasing demand for surgical infection control products, leading players in the surgical infection control market are adopting next-generation technologies to mitigate risks and potential complications associated with various surgical procedures. Leading companies in the surgical infection control market are adopting advanced technologies to introduce innovative and more effective surgical infection control products to enable healthcare professionals to offer safe and effective solutions for surgical infection control for their patients, and ultimately gain a competitive edge in the surgical infection control market.

Dominance of Leading Companies in the Surgical Infection Control Market Create Barriers for Small Companies

Tier I and Tier II companies in the surgical infection control market have invested heavily in advanced technologies and launched highly efficient tools for surgical infection control. Benefiting from high capital investments, leading players in the surgical infection control market have set the bar for effective competition in the market much higher, which is making it difficult for small businesses in the surgical infection control market to scale higher and enhance their competitive edges against leading players in the market.

Surgical Infection Control Market Segmentation

Based on the product type, the surgical infection control market is segmented into

  • Disinfectants
  • Hand Disinfectants
  • kin Disinfectants
  • Surgical Drapes
  • Surgical Gloves
  • Surgical Irrigation
  • Surgical Scrubs
  • Manual Reprocessors Solution
  • Hair Clippers
  • Medical Nonwovens
  • Skin Preparation Solution
  • Others

Based on the type of infection, the surgical infection control market segmented into

  • Organ or Space SSI
  • Superficial Incisional SSI
  • Deep Incisional SSI

Based on the surgical procedure, the surgical infection control market is segmented into

  • Dental Restoration
    • Gastric Bypass
    • Others
  • Cesarean Section
  • Cataract Surgery
  • Gastric Bypass
  • Others

Based on the end user, the surgical infection control market is segmented into

  • Ambulatory Surgical Centers
  • Hospitals

The study presents a granular assessment and quantitative evaluation of:

  • Key growth factors and prominent trends
  • Size and share of key segments in overall market
  • Key challenges and winning imperatives
  • Factors shaping competitive landscape
  • Insights into how contours of market will change in coming years
  • Technological advances
  • New avenues and imminent investment pockets
  • Regulatory landscape shaping current and future strategies of companies

The region-wise assessment includes market dynamics in:

  • North America
  • Asia Pacific
  • Europe
  • Latin America
  • The Middle East and Africa

The study is prepared with the help of an extensive primary and secondary research. Primary research includes but not limited to interactions, interviews, surveys, and events. Opinions of policy makers and industry experts are carefully integrated into the insights to complement primary research. Volumes of secondary data gleaned through renowned paid sources, annual statements, reputed journals, and government documents offer insights into current dynamics and key evolution trajectories the market is likely to assume. The research employs various industry-wide analytics methods and well-established methodologies to ascertain the attractiveness of key segments. Further, it evaluates the lucrativeness of key regions and factors underlying their maturity. The insights notably include a detailed analysis of forces behind vendor differentiation and offers insight into investment-decision making by prominent players.

The report strives to enlighten businesses and industry stakeholders on multiple facets of the growth dynamic of the market, the key of which include answers to:

  • Which key factors will shape the competitive landscape?
  • Which trends will stimulate research and development activities in different geographies?
  • Which are the lucrative growth areas and what is the size of potential they are likely contribute to the overall market?
  • Which disruptions in market growth are likely to come with the new business models?
  • Which are some of the recent overhauls in policies that may change the course of the market significantly?
  • Which are the geographies that will form sizable sources of new streams to new and established players alike?
  • How are top players likely to realign their strategy to counter the forces of competition?
  • Which key strategies emerging players are likely to focus on to consolidate their position?
  • Which changes in end-user preferences might affect the status quo held by the leading players?
  • Which are some of the game-changing innovations influencing the projected share and revenue of the market and its segments?

Note: Utmost care has invariably been taken to present data and arrive at statistics at all the TMR Research reports. Meanwhile, some recent developments and new industry trends may take time to be included in the reports.